药方
中医药
医学
萧条(经济学)
机制(生物学)
抗抑郁药
替代医学
精神科
病因学
重症监护医学
药理学
焦虑
哲学
认识论
病理
经济
宏观经济学
作者
Yiwei Chen,Ruyu Wang,Xue Li,Zhiying Wang,Baorui Cao,Jinxin Du,Tingting Deng,Jinxiang Han,Meina Yang
出处
期刊:Heliyon
[Elsevier]
日期:2024-07-26
卷期号:10 (15): e34970-e34970
标识
DOI:10.1016/j.heliyon.2024.e34970
摘要
Depression is a common psychiatric disorder that belongs to the category of "Depression Syndrome" in traditional Chinese medicine (TCM), and its etiology and pathogenesis are complex and unclear. It is characterized by high prevalence, high disability rate, and high recurrence rate, which seriously affect human health, and its treatment has become a research hotspot worldwide. At present, the antidepressants commonly used in the clinic are mainly Western medicine (WM), but there are problems such as frequent side effects and poor efficacy. Studies have found that the use of TCM prescriptions in the treatment of depression can achieve the same effect as WM; and when TCM prescriptions are combined with WM, the efficacy can be enhanced while the adverse effects of WM can be reduced. Pharmacological studies related to the treatment of depression with traditional Chinese medicine prescriptions (TCMPs) have focused on the neurobiochemical system, gut microbes, and energy metabolism in mitochondria. No one has yet reviewed the pharmacological mechanism of TCMPs for depression. So, this paper reviews the pharmacological mechanism of TCMPs for depression from the perspective of TCMPs, introduces the progress of research on classical TCMPs for depression and their antidepressant mechanism. This article aims to promote the application of TCMPs in the clinic and provide a new therapeutic idea for the clinical treatment of depression.
科研通智能强力驱动
Strongly Powered by AbleSci AI